Borkowski Astrid has filed 3 insider transactions across 1 company since February 2024.
Most recent transaction: a sale of 3933 shares of HilleVax, Inc. ($HLVX) on February 08, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 8, 2024 | HilleVax, Inc. | $HLVX | Borkowski Astrid | Chief Medical Officer | S | Common Stock | 3933 | $14.93 | 161,260.0000 | 0 | 2.38% | 0.00% |
| Feb. 8, 2024 | HilleVax, Inc. | $HLVX | Borkowski Astrid | Chief Medical Officer | A | Common Stock | 53632 | $0.00 | 214,892.0000 | 0 | 33.26% | 0.00% |
| Feb. 8, 2024 | HilleVax, Inc. | $HLVX | Borkowski Astrid | Chief Medical Officer | A | Stock Option (Right to Buy) | 69852 | $0.00 | 69,852.0000 | 0 | 9999.99% | 0.00% |